STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC.
about
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
P2860
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC.
@en
type
label
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC.
@en
prefLabel
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC.
@en
P2093
P2860
P356
P1476
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
@en
P2093
A B Kulkarni
P2860
P304
P356
10.1177/0022034517712435
P407
P577
2017-06-01T00:00:00Z